BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/10/2026 10:54:28 AM | Browse: 6 | Download: 0
| Category |
Multidisciplinary Sciences |
| Manuscript Type |
Editorial |
| Article Title |
Immune checkpoint co-expression combined with systemic inflammatory index: A promising approach in prognostic evaluation of lymphoma in Egypt
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zu-Chian Chiang, Ji-Zhen Lin and Qi Chen |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Qi Chen, Professor, Biomedical Research Center of South China, Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, No. 8 Shangsan Road, Cangshan District, Fuzhou 350117, Fujian Province, China. chenqi@fjnu.edu.cn |
| Key Words |
Lymphoproliferative neoplasms; Immune checkpoint; Co-expression; Systemic inflammatory response index; Prognostic biomarker; Hepatitis C virus; Resource-limited settings; Therapeutic monitoring |
| Core Tip |
This editorial highlights a novel prognostic model that combines immune checkpoint co-expression and the systemic inflammatory response index. Notably, programmed death-ligand 1/C-X-C motif chemokine receptor 3 co-expression accurately identifies stage IV lymphoma, while systemic inflammatory response index effectively distinguishes advanced disease and decreases with effective treatment. This low-cost biomarker system improves patient stratification, supports treatment monitoring, and promotes healthcare equity in resource-constrained settings. |
| Citation |
Chiang ZC, Lin JZ, Chen Q. Immune checkpoint co-expression combined with systemic inflammatory index: A promising approach in prognostic evaluation of lymphoma in Egypt. World J Clin Oncol 2026; In press |
 |
Received |
|
2025-12-08 00:53 |
 |
Peer-Review Started |
|
2025-12-08 00:53 |
 |
First Decision by Editorial Office Director |
|
2026-01-20 09:14 |
 |
Return for Revision |
|
2026-01-20 09:14 |
 |
Revised |
|
2026-02-02 02:03 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-03-10 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-10 10:54 |
 |
Articles in Press |
|
2026-03-10 10:54 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345